Prospects and applications of nanobiotechnology: a medical perspective

BackgroundNanobiotechnology is the application of nanotechnology in biological fields. Nanotechnology is a multidisciplinary field that currently recruits approach, technology and facility available in conventional as well as advanced avenues of engineering, physics, chemistry and biology.MethodA comprehensive review of the literature on the principles, limitations, challenges, improvements and applications of nanotechnology in medical science was performed.ResultsNanobiotechnology has multitude of potentials for advancing medical science thereby improving health care practices around the world. Many novel nanoparticles and nanodevices are expected to be used, with an enormous positive impact on human health. While true clinical applications of nanotechnology are still practically inexistent, a significant number of promising medical projects are in an advanced experimental stage. Implementation of nanotechnology in medicine and physiology means that mechanisms and devices are so technically designed that they can interact with sub-cellular (i.e. molecular) levels of the body with a high degree of specificity. Thus therapeutic efficacy can be achieved to maximum with minimal side effects by means of the targeted cell or tissue-specific clinical intervention.ConclusionMore detailed research and careful clinical trials are still required to introduce diverse components of nanobiotechnology in random clinical applications with success. Ethical and moral concerns also need to be addressed in parallel with the new developments.

[1]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[2]  S. Davis,et al.  Biomedical applications of nanotechnology--implications for drug targeting and gene therapy. , 1997, Trends in biotechnology.

[3]  Ruchika Nijhara,et al.  Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[4]  T. Webster,et al.  Selective bone cell adhesion on formulations containing carbon nanofibers. , 2003, Biomaterials.

[5]  J. Finkelstein,et al.  Translocation of Inhaled Ultrafine Manganese Oxide Particles to the Central Nervous System , 2006, Environmental health perspectives.

[6]  K. Hamad-Schifferli,et al.  Remote electronic control of DNA hybridization through inductive coupling to an attached metal nanocrystal antenna , 2002, Nature.

[7]  P. Couvreur,et al.  A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles , 2005, Cellular and Molecular Life Sciences.

[8]  K. Eric Drexler,et al.  Nanosystems - molecular machinery, manufacturing, and computation , 1992 .

[9]  Mohamed H. El-Shabouri,et al.  Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. , 2002, International journal of pharmaceutics.

[10]  W. Heckl,et al.  Nanotechnology and medicine , 2004, 4th IEEE Conference on Nanotechnology, 2004..

[11]  Kai Ewert,et al.  Lipoplex structures and their distinct cellular pathways. , 2005, Advances in genetics.

[12]  C. Mirkin,et al.  Protein Nanoarrays Generated By Dip-Pen Nanolithography , 2002, Science.

[13]  D. A. Kharkevich,et al.  Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. , 1998, Journal of microencapsulation.

[14]  John Samuel,et al.  Analysis of Poly(D,L-Lactic-Co-Glycolic Acid) Nanosphere Uptake by Human Dendritic Cells and Macrophages In Vitro , 2002, Pharmaceutical Research.

[15]  K. Arvidson,et al.  Rehabilitation of mandibular edentulism by single crystal sapphire implants and overdentures: 3-12 year results in 86 patients. A dual center international study. , 1996, Clinical oral implants research.

[16]  M. Bednarski,et al.  Vascular-targeted nanoparticles for molecular imaging and therapy. , 2004, Methods in enzymology.

[17]  Thomas J. Webster,et al.  Nano-biotechnology: carbon nanofibres as improved neural and orthopaedic implants , 2004, Nanotechnology.

[18]  M. Morandi,et al.  Nanoparticle‐induced platelet aggregation and vascular thrombosis , 2005, British journal of pharmacology.

[19]  M. Radomski,et al.  Nanoparticles: pharmacological and toxicological significance , 2007, British journal of pharmacology.

[20]  Jian Yi Li,et al.  Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer. , 2003, Molecular vision.

[21]  M. Alonso,et al.  Nanoparticles as carriers for nasal vaccine delivery , 2005, Expert review of vaccines.

[22]  S. Sahoo,et al.  Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.

[23]  Kevin Robbie,et al.  Nanomaterials and nanoparticles: Sources and toxicity , 2007, Biointerphases.

[24]  Catherine Shaffer.  Nanomedicine transforms drug delivery. , 2005, Drug discovery today.

[25]  David Williams.  The risks of nanotechnology. , 2005, Medical device technology.

[26]  Liandong Hu,et al.  Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs , 2004, The Journal of pharmacy and pharmacology.

[27]  David Ure,et al.  Nanotechnology in dentistry: reduction to practice. , 2003, Dental update.

[28]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[29]  S. Hart.  Lipid carriers for gene therapy. , 2005, Current drug delivery.

[30]  Anna Shvedova,et al.  Cardiovascular Effects of Pulmonary Exposure to Single-Wall Carbon Nanotubes , 2006, Environmental health perspectives.

[31]  Patrick Winter,et al.  Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Gilles Ponchel,et al.  Gliadin Nanoparticles as Carriers for the Oral Administration of Lipophilic Drugs. Relationships Between Bioadhesion and Pharmacokinetics , 2001, Pharmaceutical Research.

[33]  Feng Zhao,et al.  Acute toxicological effects of copper nanoparticles in vivo. , 2006, Toxicology letters.

[34]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[36]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[38]  V. Labhasetwar,et al.  Nanosystems in Drug Targeting: Opportunities and Challenges , 2005 .

[39]  L. Young,et al.  Viral gene therapy strategies: from basic science to clinical application , 2006, The Journal of pathology.

[40]  T. Yotsuyanagi,et al.  [Cationic liposomes in gene delivery]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.

[41]  L. Oesterle,et al.  Uprighting molars without extrusion. , 1999, Journal of the American Dental Association.

[42]  J L West,et al.  Applications of nanotechnology to biotechnology commentary. , 2000, Current opinion in biotechnology.

[43]  Si-Shen Feng,et al.  Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. , 2004, Current medicinal chemistry.

[44]  H. Slavkin.  Entering the era of molecular dentistry. , 1999, Journal of the American Dental Association.

[45]  Buddy D. Ratner,et al.  Template-imprinted nanostructured surfaces for protein recognition , 1999, Nature.

[46]  M. A. Arangoa,et al.  Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[47]  V. Labhasetwar,et al.  Targeted Drug Delivery in Cancer Therapy , 2005, Technology in cancer research & treatment.

[48]  P. Couvreur,et al.  Intraocular injection of tamoxifen‐loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis , 2004, European journal of immunology.

[49]  E. Oberdörster.  Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile Largemouth Bass , 2004, Environmental health perspectives.

[50]  Praveen Elamanchili,et al.  Biodegradable Nanoparticle Mediated Antigen Delivery to Human Cord Blood Derived Dendritic Cells for Induction of Primary T Cell Responses , 2003, Journal of drug targeting.

[51]  Robert Langer,et al.  Moving smaller in drug discovery and delivery , 2002, Nature Reviews Drug Discovery.